What ROKIT Genomics does

ROKIT Genomics is a South Korean contract genomics services provider founded in 2019 and headquartered in Seoul. The company offers an end-to-end portfolio of sequencing and bioinformatics services spanning single-cell sequencing, spatial transcriptomics, whole genome sequencing, transcriptome sequencing, epigenome sequencing, and metagenome sequencing. Service delivery is multi-platform, leveraging capture technologies from 10X Genomics (Chromium), BD Biosciences (Rhapsody), and MobiDrop (MobiNova), with sequencing performed on Illumina NovaSeq and PacBio Sequel II/Revio instruments. The company supports projects from sample QC through customized downstream bioinformatics analysis, with standard single-cell turnaround of 4-5 weeks.

The company monetizes via quote-based project services rather than disclosed pricing. Its primary customer base is Korean government health and research agencies (Korea Disease Control and Prevention Agency, Ministry of Food and Drug Safety, National Cancer Center, Korea Institute of Oriental Medicine, Korea Institute of Chemical Technology Safety Evaluation) supplemented by universities (Pusan National University, Chonnam National University) and pharmaceutical/biotech clients. Distribution is direct-to-customer with no public channel partnerships. ROKIT has also developed and launched a proprietary software asset, C-DIAM, providing single-cell multiomics analysis capability, and has signed MOUs with BD Korea, Bertis, BioSolvix, and Macrogen to extend its analytical reach.

ROKIT is a small organization (1-10 employees) operating exclusively in Korea. Its competitive position depends on multi-platform flexibility, accumulated government-research credibility, and its proprietary C-DIAM analytics layer. The firm participates in trade shows such as BioKorea for industry expansion and has received 2024 awards including Asia-Pacific Best Single Cell Analysis Company (Life Sciences Review APAC) and the Excellent R&D Award at the 10th Korea Excellent Company Awards. No funding rounds, acquisitions, or revenue disclosures are available in the source data.

Name

ROKIT Genomics

Legal name

ROKIT Genomics

Website

https://rokitgenomics.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

ROKIT Genomics is a Seoul-based private genomics services company offering single-cell sequencing, spatial transcriptomics, and multiomics bioinformatics on Illumina, PacBio, 10X, and BD platforms, serving Korean government research agencies, universities, and biotech clients.

Ownership category

akta.pro rank

Product category

Genomics Sequencing Services

NAICS

Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Transcriptomics & Gene Expression Profiling Services (HLAGANAE)

akta.pro secondary industries

Epigenomics & Chromatin Profiling Services (HLAGANAF), Microbiome & Metagenomics Services (HLAGANAH), Genomic & Multi-Omic Biomarkers (NGS panels, transcriptomics, proteomics, metabolomics) (HLAAAMAJ), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD)

Keywords

• Single cell sequencing
• Spatial transcriptomics
• Genomics services
• Multiomics analysis
• Bioinformatics analysis

Headquarters

HQ city

Seoul

HQ country

South Korea

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Services

Cost components

Technology or R&D, Personnel, Operations, Infrastructure, Marketing or Sales

Distribution channels1 record

Marketing channels2 records

Core offering

ROKIT Genomics is a South Korea-based genomics services company that provides end-to-end sequencing and bioinformatics analysis for research institutions, government agencies, and biotech clients. Its core offerings include single cell sequencing, spatial transcriptomics, genome sequencing, transcriptome sequencing, epigenome sequencing, and metagenome sequencing, supported by professional bioinformatic analysis and the proprietary C-DIAM multiomics platform. Services span consultation, sample QC, tissue dissociation, library preparation, multi-platform sequencing (10X Genomics, BD Rhapsody, MobiDrop, Illumina NovaSeq, PacBio Sequel II/Revio), and customized data analysis.

Product overview

ROKIT Genomics is a genomics services company offering a comprehensive portfolio of sequencing and analysis services. The core offerings include Single Cell Sequencing (with workflow from consulting through analysis), Genome Sequencing, Transcriptome Sequencing, Epigenome Sequencing, Metagenome Sequencing, and Spatial Transcriptomics. These services are supported by dedicated Bioinformatic Analysis capabilities. The company utilizes major sequencing platforms including 10X Genomics Chromium, BD Biosciences Rhapsody, MobiDrop MobiNova, Illumina NovaSeq, and PacBio Sequel II/Revio. Additional offerings include the C-DIAM Multiomics Platform for single-cell analysis and Tissue Dissociation Service as preprocessing support.

Differentiator

Problem solved

Functional benefit

Products and services

• Single Cell Sequencing (단일세포 시퀀싱) End-to-end single cell RNA-seq service covering consulting, free pre-QC testing, platform selection, tissue dissociation, single cell capture, library preparation, Illumina NovaSeq sequencing, and customized bioinformatics analysis. Targets 5,000-50,000 cells with >90% viability and 4-5 week turnaround after sample QC. Designed for academic, government, and biotech researchers needing high-quality single cell transcriptomic data.
• Spatial Transcriptomics (공간 전사체학) Service that analyzes gene expression patterns while preserving spatial context within tissue samples, enabling researchers to map transcriptomic activity to tissue architecture.
• Genome Sequencing (유전체 시퀀싱) Whole genome sequencing service run on Illumina NovaSeq (short-read, DNA >500ng) or PacBio Sequel II (long-read, 1-3µg). Delivers variant calling and whole genome reference rebuilding for researchers studying genetic variants, mutations, and population genetics.
• Transcriptome Sequencing (전사체 시퀀싱) Comprehensive transcriptome profiling including mRNA expression analysis (RNA >0.1-1µg, RIN>7), miRNA profiling (>0.5µg, RIN>7), small RNA profiling, and full-length isoform sequencing on PacBio platforms. Includes differential expression, GO analysis, and functional annotation.
• Epigenome Sequencing (후성유전체 시퀀싱) Epigenomic analysis covering methylation calling in CpG context (DNA >3µg, DIN>6) or all contexts (DNA >6µg, DIN>8), methylation pattern analysis, and Differentially Methylated Region (DMR) detection for researchers studying gene regulation and epigenetic biomarkers.
• Metagenome Sequencing (미생물군집 유전체 시퀀싱) Metagenomic sequencing via 16S rRNA amplicon analysis (V3-V4 region or full-length) on Illumina NovaSeq or PacBio Sequel II. Delivers ASV detection, diversity statistics, taxonomy classification, and functional prediction for microbiome studies.
• Bioinformatic Analysis (생물정보학 분석) Professional bioinformatics analysis service supporting all sequencing platforms. Includes data processing, statistical analysis, visualization (PCA, heatmap), differential expression analysis, functional annotation, and customized downstream analysis for any omics dataset generated by ROKIT Genomics or supplied by the client.
• C-DIAM Multiomics Platform Proprietary single-cell transcriptomics analysis platform launched in Korea for multiomics data integration. Enables researchers to perform integrated single cell analysis across multiomics datasets.

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

Feature3 records

Partnerships

Four partnerships are on record, tiered core and minor.

• BD Korea (BD Rhapsody)coreTechnology or Integration · 20 November 2024MOU for BD Rhapsody-based single cell analysis and utilization services. ROKIT Genomics provides single cell sequencing services using BD Biosciences Rhapsody platform, enabling customers to access BD's single cell technology through ROKIT's service offerings.
• BertiscoreStrategic or Co-development Partner · 26 August 2024MOU for proteome and genome analysis service collaboration. Partnership combines Bertis's proteomics capabilities with ROKIT Genomics's genomics and single cell analysis expertise to provide comprehensive multiomics services.
• BioSolvixminorStrategic or Co-development Partner · 15 March 2024Business partnership agreement (MOU) for collaborative work in genomics analysis services.
• MacrogenminorStrategic or Co-development PartnerCollaboration for genomics services expansion as referenced in PR materials showing joint activities.

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Azenta (GENEWIZ): Azenta Life Sciences (formerly GENEWIZ) is a global genomics services provider offering Sanger, NGS, and next-generation sequencing services to academic and biopharma customers. It competes with ROKIT for outsourced NGS and multiomics projects and represents a scaled global alternative.
• Novogene: Novogene is a large global genomics services provider offering NGS, single-cell, epigenomics, and de novo sequencing across APAC, the Americas, and Europe. It is comparable to ROKIT in the sequencing-service offering but operates at much larger scale and broader geographic reach.
• BGI Genomics: BGI Genomics is one of the world's largest genomics services and sequencing-platform companies, offering WGS, single-cell, and clinical sequencing globally. It overlaps with ROKIT in single-cell and multiomics services and represents a high-volume incumbent competing for the same Asian research accounts.
• Eurofins Genomics: Eurofins Genomics is a division of Eurofins Scientific offering DNA sequencing, genomics, and bioinformatics services worldwide with industrial-scale capacity. It is comparable to ROKIT as a sequencing-services provider but operates at much larger scale with broad global reach.

Direct peers

• Macrogen: Macrogen is a large Korean genomics services provider offering Sanger, NGS, single-cell, and clinical sequencing to academic and clinical customers globally. It is ROKIT's most direct Korean competitor and is also named as a collaborator in ROKIT's PR materials.
• Psomagen: Psomagen (formerly Macrogen USA) provides NGS, single-cell, and multiomics services to academic and biopharma clients with deep Korean heritage. It is comparable to ROKIT because it sells single-cell and multiomics services globally from a Korean-rooted service platform.
• DNA Link: DNA Link is a Korean genomics services provider offering NGS, microbiome, and bioinformatics to research and clinical customers. It competes with ROKIT in the same Korean research-services market, particularly in microbiome and exome/NGS workflows.
• Theragen Bio: Theragen Bio is a Korean precision-medicine and genomics services company offering NGS panels, pharmacogenomics, and bioinformatic analysis to hospitals, pharma, and government research. It targets the same Korean academic, clinical, and government accounts as ROKIT with overlapping sequencing and analysis offerings.
• Singleron Biotechnologies: Singleron is a single-cell sequencing-focused company offering its own capture chemistry plus services across scRNA-seq, snRNA-seq, and multiomics. It directly competes with ROKIT in the single-cell services market and is expanding in APAC.

Emerging players

• CD Genomics: CD Genomics is a US-based genomics services provider offering NGS, single-cell, epigenomics, metagenomics, and bioinformatics to global research customers. It competes with ROKIT for single-cell and multiomics service projects, particularly from international biopharma clients.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/rokit-genomics

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ROKIT Genomics